论文部分内容阅读
目的探讨舒利迭联合孟鲁司特治疗哮喘的临床效果。方法将我院收治的78例哮喘患者,随机分为对照组和观察组,对照组采用舒利迭治疗,观察组在对照组的基础上加用孟鲁司特治疗。分析观察组和对照组的治疗效果及不良反应发生情况。结果对照组总有效率74.4%,观察组总有效率94.9%。观察组总有效率显著高于对照组,差异有统计学意义(P<0.05)。两组治疗过程中均未见明显不良反应发生。结论采用舒利迭联合孟鲁司特治疗疗效优于单用舒利迭治疗,不良反应少,使用方便,值得临床推广应用。
Objective To investigate the clinical efficacy of seretide combined with montelukast in the treatment of asthma. Methods 78 asthma patients admitted to our hospital were randomly divided into control group and observation group. The control group was treated with seretide. The observation group was treated with montelukast on the basis of the control group. Analysis of observation group and control group, the treatment effect and adverse reactions. Results The total effective rate was 74.4% in the control group and 94.9% in the observation group. The total effective rate of the observation group was significantly higher than that of the control group, the difference was statistically significant (P <0.05). No significant adverse reactions occurred in both groups during the course of treatment. Conclusion The combination of seretide and montelukast is superior to seretide alone, with fewer side effects and convenient use. It is worthy of clinical application.